| VKTX Snapshot | |
|---|---|
| Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders. The company is headquartered in San Diego, California. | |
| VALUATION DATA | |
| Market Capitalization | $171,770,000 | Price to Sales | 0.00 |
| Earnings per Share | $-0.7330 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $2.2500 |
| 52 Week High | $7.2 |
| 52 Week Low | $2.15 |
| 50-Day Moving Average | $2.729 |
| 200-Day Moving Average | $4.58 |
| All data are from Alpha Vantage as of today. For more infomation on VKTX see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search